Tesla, Twitter

Shares of the electric vehicle maker fell 1.5% in the premarket after CEO Elon Musk reversed course on his Twitter purchase, proposing once again to take over the social media company for $54.20 per share. Previously, he tried to back out of buying the company, but Twitter sued him to go through with the purchase. Twitter shares slipped 0.6% after rallying on the news Tuesday.

Also Read | Twitter Blue subscribers will soon have edit feature: All you need to know


The online travel platform’s stocks added 0.8% in the premarket, outperforming the broader market after Bernstein started coverage of the stock with an outperform rating and a price target that implies an upside of around 30% from Tuesday’s close. 

Also Read | Once upon a time: Rupee’s journey from 4 to 80 a dollar

Cruise lines 

The major cruise lines slipped in premarket trading after jumping during Tuesday trading when Norwegian Cruise Line said it would slip Covid-19 testing, masking, and vaccination requirements. The stock slipped 2% on Wednesday, while Carnival and Royal Caribbean lost 2.3% and 1.9%, respectively.

Also Read | Donald Trump goes to Supreme Court over Mar-a-Lago raid and document seizure


Ford gained 1.5% in premarket action after Morgan Stanley upgraded the stock to overweight from equal weight, citing a potential buying opportunity after the stock’s recent decline. General Motors slipped 1.8% after the company lowered its price target on the stock. Ford Motor will end production of its $500,000 GT supercar later this with a special edition model paying tribute to the vehicle’s racing heritage. 

Also Read | Billionaire Ray Dalio steps down as Co-CIO of Bridgewater Associates

Morgan Stanley, Goldman Sachs

Shares of Morgan Stanley fell 1.4% and Goldman Sachs lost 1.6% after Atlantic Equities downgraded both stocks due to the potential of declining investment banking volume.

Also Read | Justice Department ‘privilege review’ team to return 300 documents to Donald Trump

Bionano Genomics

Shares surged 11.3% in premarket trading after the company published a study showing the use of optical genome mapping (OGM) to investigate a molecular subgroup of hepatocellular carcinoma (HCC), which is the most common form of liver cancer, in order to explore the complex structural variations (SVs) induced by replication stress.